A Phase 1, 2-Part Study to Evaluate the Relative Bioavailability of and Food-Effect on Pharmacokinetics of Different Formulations of S-337395, and to Assess the Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of S-337395 in Healthy Adult Participants
Latest Information Update: 18 Jul 2024
At a glance
- Drugs S-337395 (Primary)
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Shionogi
Most Recent Events
- 10 Jul 2024 Status changed from recruiting to completed.
- 04 Mar 2024 Planned initiation date (estimated date for recruitment of the first subject) changed from 14 Feb 2024 to 28 Mar 2024.
- 04 Mar 2024 Status changed from not yet recruiting to recruiting.